Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.3 to the Record History and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe Record History adds revision v3.3.2 and removes v3.2.0 in the version list.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check63 days agoChange DetectedThe history shows multiple updates to study status and recruitment status across several versions. These changes reflect ongoing updates to the trial's progress and enrollment.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdate announces version v3.2.0 and adds a government funding status notice with operating details; removes the previous v3.1.0 tag. The core page now communicates current operating status and a higher-level version indicator.SummaryDifference12%

- Check99 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.